Management of carcinoma of the skin in solid organ transplant recipients with oral capecitabine.
Endrizzi
Bart T
BT
Department of Dermatology, University of Minnesota. MN 55455-0392, USA. bart.endrizzi@gmail.com
Lee
Peter K
PK
D000284:Administration, Oral; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D000069287:Capecitabine; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D005472:Fluorouracil / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D016377:Organ Transplantation; D011230:Precancerous Conditions / Q000209:etiology / Q000517:prevention & control*; D012878:Skin Neoplasms / Q000209:etiology / Q000517:prevention & control*
D000964:Antimetabolites, Antineoplastic; D007166:Immunosuppressive Agents; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil